Emma Proctor British entrepreneur whose basal cell carcinoma was detected using a mobile app Date of Birth: 01.01.1981 Country: Great Britain

1. SkinVision: A Life-Saving Tool
2. Diagnosis and Treatment
3. The Importance of Early Detection
4. Basal Cell Carcinoma: Understanding the Risks
5. SkinVision: How It Works
6. SkinVision's Proven Accuracy
7. Treatment Options for BCC
8. Eric de Heus, CEO of SkinVision:

Emma Proctor's Skin Cancer Journey: Early Detection through Mobile App

Emma Proctor, a 37-year-old British entrepreneur, was previously an avid sunbed user for over ten years. However, after discontinuing the practice due to premature aging, a mole on her lower back began changing appearance, itching, and bleeding.

SkinVision: A Life-Saving Tool

Instead of seeking medical attention, Emma consulted the SkinVision app, which recommends professional assessment if it detects potential cancer risks. The app analyzed the mole and prompted her to visit her general practitioner, who referred her to a dermatologist.

Diagnosis and Treatment

The dermatologist confirmed the presence of basal cell carcinoma (BCC), a non-melanoma skin cancer. Emma underwent a surgical procedure to remove the mole, which revealed the complete removal of the cancerous cells.

The Importance of Early Detection

Emma attributes her early detection to the SkinVision app. Without it, she might have waited longer to seek medical help, potentially leading to a more severe condition. The app provides a convenient way to monitor skin changes and enables users to take control of their skin health.

Basal Cell Carcinoma: Understanding the Risks

BCC is the most common type of skin cancer in the UK, affecting approximately 100,000 people annually. It is primarily caused by excessive exposure to ultraviolet (UV) rays from the sun or tanning beds. People with fair skin, those who work outdoors, and those who have used tanning beds are at an increased risk.

SkinVision: How It Works

SkinVision is a mobile app that assesses skin cancer risk by analyzing moles. Users upload photographs of their moles, and the app evaluates factors such as asymmetry and shape. The app provides risk assessments and recommends whether further action is required.

SkinVision's Proven Accuracy

Studies have demonstrated that SkinVision has an accuracy rate of over 95%. It has helped many individuals detect skin cancer early and receive timely treatment. Emma's story is a testament to the app's effectiveness in aiding early detection and preventing potentially serious outcomes.

Treatment Options for BCC

The primary treatment for BCC is surgery, which is successful in over 90% of cases. Other treatment options include chemotherapy, cryotherapy, and photodynamic therapy.

Eric de Heus, CEO of SkinVision:

"We are thrilled that we could play a part in Emma's journey and help her get the correct diagnosis and treatment she needed."